AIA Group Limited — Board/Management Information 2012

Nov 20, 2012

This announcement is for information purposes only and does not constitute an invitation or offer by any person to acquire, purchase or subscribe for securities. This announcement is not, and is not intended to be, an offer of securities of the Company for sale in the United States. The securities of the Company have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”) and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements under the U.S. Securities Act. There is not, and is not intended to be, any public offering of the securities of the Company in the United States.

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [65 x 70] intentionally omitted <==

AIA Group Limited 友邦保險控股有限公司

(Incorporated in Hong Kong with limited liability)

Stock Code: 1299

APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR

The Board of Directors (the “Board”) of AIA Group Limited (the “Company”) is pleased to announce the appointment of Dr. Narongchai Akrasanee as an Independent Non-executive Director of the Company. He will also serve as a member of the Risk Committee and Nomination Committee of the Company. These appointments take effect from 21 November 2012.

Dr. Narongchai, aged 67, is a former Minister of Commerce for Thailand and a Senator and has acted as advisor to several Thai Prime Ministers. He retired as Chairman of the Export-Import Bank of Thailand in June 2010. Dr. Narongchai also served as a Director of the Office of the Insurance Commission of Thailand during the period from October 2007 to August 2012. He is currently a Director of the National Economic and Social Development Board, Chairman of the Thailand National Committee for the Pacific Economic Cooperation Council and a member of the Monetary Policy Committee of the Bank of Thailand.

Dr. Narongchai also acts as a director for certain entities listed on the Stock Exchange of Thailand including acting as Chairman of MFC Asset Management Public Company Limited, Vice Chairman and an independent director of Thai-German Products Public Company Limited and as an independent director of Malee Sampran Public Company Limited. He is also Chairman and an independent director of The Brooker Group Public Company Limited which is listed on the Stock Exchange of Thailand’s Market for Alternative Investment and is Chairman of Ananda Development Public Company Limited.

Dr. Narongchai received a Bachelor degree in Economics with honours from the University of Western Australia and M.A. and Ph.D. in Economics from Johns Hopkins University.

Dr. Narongchai confirmed that he meets the independence criteria as set out in Rule 3.13 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the “Listing Rules”).

1

Dr. Narongchai is entitled to receive an annual director’s fee of US$155,000 and an annual fee of US$25,000 and US$10,000 for acting as a member of the Risk Committee and Nomination Committee, respectively. The fees were set by the Remuneration Committee with reference to the duties and responsibilities within the Company and prevailing market conditions. The fees are covered by and stipulated in a service contract with the Company.

Dr. Narongchai’s appointment is for a term of 3 years commencing on 21 November 2012, subject to retirement by rotation and re-election in accordance with the articles of association of the Company.

As at the date of this announcement, Dr. Narongchai does not have any interest or short position in shares, underlying shares or debentures of the Company or any of its associated corporations within the meaning of Part XV of the Securities and Futures Ordinance.

Save as disclosed above, Dr. Narongchai has not held any other directorships in other Hong Kong and overseas listed public companies in the last three years. Other than the positions disclosed above, Dr. Narongchai does not hold any position in the Company or any of its subsidiaries. Dr. Narongchai does not have any relationship with any director, senior management, substantial or controlling shareholders of the Company.

Dr. Narongchai confirmed that there is no other information relating to him that is required to be disclosed pursuant to Rule 13.51(2) of the Listing Rules and there are no other matters which need to be brought to the attention of the shareholders of the Company in connection with his appointment.

By order of the Board Mark Edward Tucker Executive Director, Group Chief Executive and President

Hong Kong, 20 November 2012

As at the date of this announcement, the Board of Directors of the Company comprises:

Non-executive Chairman and Non-executive Director:

Mr. Edmund Sze-Wing Tse

Executive Director, Group Chief Executive and President: Mr. Mark Edward Tucker

Independent Non-executive Directors:

Mr. Jack Chak-Kwong So, Mr. Chung-Kong Chow, Dr. Qin Xiao, Mr. John Barrie Harrison, Mr. Barry Chun-Yuen Cheung and Mr. George Yong-Boon Yeo

2